Extracorporeal membrane oxygenation (ECMO) technology has relative contraindications in haemorrhagic disease but remains an effective therapeutic option for the treatment of pulmonary haemorrhage ...
Having more severe chronic lung disease does not predict worse pulmonary hypertension outcomes in infants born preterm, a new study found.